Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03823014 · ClinicalTrials.gov registry record · NA
Use of an External Erectile Device in Transgender Man Following Phalloplasty
A NA study of Surgery and Erectile Dysfunction, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03823014: Completed NA study of Surgery and Erectile Dysfunction, sponsored by Boston Children's Hospital.
NCT03823014 is a NA study of Surgery and Erectile Dysfunction that has completed, run by Boston Children's Hospital. The registered enrollment target is 15 participants, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03823014, a NA study of Surgery and Erectile Dysfunction, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men who have undergone a phalloplasty with glansplasty and wish to use their neophallus for sexual penetration. The Elator™ was initially developed for men experiencing erectile dysfunction after prostate cancer. The device consists of two silicone rings connected by a pair of plastic coated rigid metal rods. One ring goes at the base of the penis. The other ring is connected to the rods. This ring is placed behind the glans, and then the rods are connected to the base ring to stretch and provide rigidity to the phallus.
Primary Outcome
Brief measure of quality of most recent sexual experience
Conditions Studied
Interventions
- DEVICE Elator
Study Locations (1)
Massachusetts
- Participation in this study is from participants home. - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT03823014 record still lists
NCT03823014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Elator is the first listed.
NCT03823014 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03823014 about?
NCT03823014 is a clinical study titled "Use of an External Erectile Device in Transgender Man Following Phalloplasty". The purpose of this study is to test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men who have undergone a phalloplasty with glansplasty and wish to use their neophallus for sexual penetration. The Elator™ was initial...
What is the current status of trial NCT03823014?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-07-01. Estimated completion is 2022-07-01.
What conditions does trial NCT03823014 study?
This clinical trial studies the following conditions: Surgery, Erectile Dysfunction, Sex Behavior, Transsexualism.
What interventions are being tested in trial NCT03823014?
The interventions under investigation include: Elator (DEVICE).
Who is sponsoring clinical trial NCT03823014?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03823014 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03823014's enrollment target sits among peer trials
15 118th of 120 higher than 2 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
-
Gastric US in ICU Patient
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI